Vanguard Portfolio Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Vanguard Portfolio Management's IMVT Position: Q3 2026 in Review
Vanguard Portfolio Management increased its Immunovant (IMVT) stake by 9.1% in Q3 2026, buying an estimated $14M and bringing the position to 4,264,743 shares worth $144M. The position accounts for 0.01% of the portfolio, ranked #1335.
Vanguard Portfolio Management first reported a position in IMVT in Q1 2026 and has held it in 3 quarters since. The position peaked at $151M in Q2 2026. 231 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Vanguard Portfolio Management held 4,264,743 shares of Immunovant worth $144M as of Q3 2026.
- Vanguard Portfolio Management bought 354,234 Immunovant shares in Q3 2026, an estimated $14M.
- Immunovant made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1335 holding.
- Vanguard Portfolio Management first reported a position in Immunovant in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Immunovant position peaked at $151M in Q2 2026.
- 231 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.